Viatris, Inc. (VTRS)
13.80
+0.28
(+2.11%)
USD |
NASDAQ |
Mar 17, 16:00
13.80
0.00 (0.00%)
After-Hours: 20:00
Viatris EPS Diluted (Quarterly) : -0.2951 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | -0.2898 |
| Baxter International, Inc. | -2.160 |
| West Pharmaceutical Services, Inc. | 1.817 |
| Eli Lilly & Co. | 7.024 |
| Boston Scientific Corp. | 0.4493 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -340.10M |
| Revenue (Quarterly) | 3.705B |
| Total Expenses (Quarterly) | 4.046B |
| Enterprise Value | 28.80B |
| Gross Profit Margin (Quarterly) | 40.28% |
| Profit Margin (Quarterly) | -9.18% |
| Earnings Yield | -21.46% |
| Operating Earnings Yield | 7.07% |
| Normalized Earnings Yield | -6.713 |